XML 59 R33.htm IDEA: XBRL DOCUMENT v3.24.0.1
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)
12 Months Ended
Dec. 31, 2023
Accounting Policies [Abstract]  
Schedule of Computation of Basic and Diluted Earnings Per Share
The table below presents the computation of basic and diluted earnings per share (in millions, except for per share information):
 Years Ended December 31,
 202320222021
Basic:   
Net income attributable to Edwards Lifesciences Corporation$1,402.4 $1,521.9 $1,503.1 
Weighted-average shares outstanding606.7 619.0 623.3 
Basic earnings per share$2.31 $2.46 $2.41 
Diluted:
Net income attributable to Edwards Lifesciences Corporation$1,402.4 $1,521.9 $1,503.1 
Weighted-average shares outstanding606.7 619.0 623.3 
Dilutive effect of stock plans2.7 5.2 7.9 
Dilutive weighted-average shares outstanding609.4 624.2 631.2 
Diluted earnings per share$2.30 $2.44 $2.38 
Schedule of Stock-Based Compensation Expense
Total stock-based compensation expense was as follows (in millions):
 Years Ended December 31,
 202320222021
Cost of sales$23.6 $22.8 $20.4 
Selling, general, and administrative expenses82.4 75.3 65.6 
Research and development expenses33.4 28.7 23.3 
Total stock-based compensation expense139.4 126.8 109.3 
Income tax benefit(24.1)(21.6)(18.9)
Total stock-based compensation expense, net of tax$115.3 $105.2 $90.4